% Expired Patents = 14.3

Forward Citations = 7

Loading Chart...

6 inventors (with patents filed for the assignee):

Timor Baasov (6 out of 22 patents)

Shmuel Tuvia (3 out of 3 patents)

Michael Mizhiritskii (1 out of 10 patents)

4. Mani Bushan Kotala (1 out of 1 patent)

5. Ravinder Palidi (1 out of 1 patent)

6. Dori Pelled (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 11786539 - Aminoglycoside derivatives and uses thereof in treating genetic disorders (2023-10-17),

2. 11613551 - Aminoglycoside derivatives and uses thereof in treating genetic disorders (2023-03-28),

3. 11306115 - Aminoglycoside derivatives and uses thereof in treating genetic disorders (2022-04-19),

4. 11136345 - Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof (2021-10-05),

5. 10899785 - Aminoglycoside derivatives and uses thereof in treating genetic disorders (2021-01-26),

6. 10786520 - Aminoglycoside derivatives and uses thereof in treating genetic disorders (2020-09-29),

7. 10576095 - Use of aminoglycoside analogs in the treatment of Rett syndrome (2020-03-03),

Company Overview

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of rare and ultra-rare genetic diseases. The company's lead product candidate, ELX-02, is being studied for the treatment of cystic fibrosis and other genetic disorders. Eloxx Pharmaceuticals is committed to improving the lives of patients with unmet medical needs through the advancement of innovative therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#45 in Rehovot

#911 in Israel

Rehovot, Israel

Eloxx Pharmaceuticals Ltd.

Forward Citations = 7

6 inventors:

Timor Baasov (6 out of 22 patents)

Shmuel Tuvia (3 out of 3 patents)

Michael Mizhiritskii (1 out of 10 patents)

4. Mani Bushan Kotala (1 out of 1 patent)

5. Ravinder Palidi (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eloxx Pharmaceuticals Ltd.. Retrieved from https://idiyas.com/company/eloxx-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]